rs7862315
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001110303.4(USP20):c.135+168G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.864 in 152,312 control chromosomes in the GnomAD database, including 57,235 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.86 ( 57235 hom., cov: 34)
Consequence
USP20
NM_001110303.4 intron
NM_001110303.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.55
Genes affected
USP20 (HGNC:12619): (ubiquitin specific peptidase 20) This gene encodes a ubiquitin specific processing protease that was first identified as a substrate of the VHL (von Hippel-Lindau disease) protein E3 ubiquitin ligase complex. In addition to being ubiquitinated by the VHL-E3 ligase complex, this enzyme deubiquitinates hypoxia-inducible factor (HIF)-1 alpha and thereby causes increased expression of HIF-1alpha targeted genes which play a role in angiogenesis, glucose metabolism, cell proliferation and metastasis. The enzyme encoded by this gene also regulates G-protein coupled receptor signaling by mediating the deubiquitination of beta-2 adrenergic receptor (ADRB2). This enzyme is a ubiquitously expressed thiolester hydrolase. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.954 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP20 | NM_001110303.4 | c.135+168G>A | intron_variant | Intron 4 of 25 | ENST00000372429.8 | NP_001103773.2 | ||
USP20 | NM_001008563.5 | c.135+168G>A | intron_variant | Intron 4 of 25 | NP_001008563.2 | |||
USP20 | NM_006676.8 | c.135+168G>A | intron_variant | Intron 4 of 24 | NP_006667.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP20 | ENST00000372429.8 | c.135+168G>A | intron_variant | Intron 4 of 25 | 1 | NM_001110303.4 | ENSP00000361506.3 | |||
USP20 | ENST00000315480.9 | c.135+168G>A | intron_variant | Intron 4 of 24 | 1 | ENSP00000313811.4 | ||||
USP20 | ENST00000358355.5 | c.135+168G>A | intron_variant | Intron 4 of 25 | 1 | ENSP00000351122.1 | ||||
USP20 | ENST00000494971.2 | n.359+168G>A | intron_variant | Intron 4 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.864 AC: 131539AN: 152194Hom.: 57198 Cov.: 34
GnomAD3 genomes
AF:
AC:
131539
AN:
152194
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.864 AC: 131631AN: 152312Hom.: 57235 Cov.: 34 AF XY: 0.871 AC XY: 64887AN XY: 74490
GnomAD4 genome
AF:
AC:
131631
AN:
152312
Hom.:
Cov.:
34
AF XY:
AC XY:
64887
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3251
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at